BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 520763)

  • 1. A technique for multiparametric analysis of hemodynamic changes in rat urinary bladder during carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Lurie AG; Rippey RM; Conran PB; Tatematsu M; Ito N
    Gan; 1979 Oct; 70(5):717-8. PubMed ID: 520763
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N
    Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract]   [Full Text] [Related]  

  • 4. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
    Tatematsu M; Miyata Y; Mizutani M; Hananouchi M; Hirose M
    Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Moon RC
    J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573
    [No Abstract]   [Full Text] [Related]  

  • 6. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Tatematsu M; Lurie AG; Rippey RM; Conran PB; Arai M; Fukushima S; Ito N
    Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
    J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low susceptibility of nude mice to induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine.
    Tamano S; Shirai T; Kawabe M; Ni-I H; Mori Y; Okada M; Fukushima S
    Toxicol Pathol; 1992; 20(2):205-11. PubMed ID: 1475581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB
    Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of enhancing effect of mucosal regeneration following ulceration of the urinary bladder on N-butyl-N-(4-hydroxybutyl)nitrosamine carcinogenesis in rats.
    Shirai T
    Cancer Res; 1980 Oct; 40(10):3709-12. PubMed ID: 7438054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell origin of bladder cancer induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice with cellular mosaicism.
    Kakizoe T; Tanooka H; Tanaka K; Sugimura T
    Gan; 1983 Aug; 74(4):462-5. PubMed ID: 6628898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular changes during rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Tatematsu M; Cohen SM; Fukushima S; Shinohara Y; Ito N
    Gan; 1977 Feb; 68(1):127-8. PubMed ID: 863173
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of reduced glutathione on N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in rats].
    Komatsu H; Kakizoe T; Nishio Y; Honma Y; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2077-80. PubMed ID: 6677790
    [No Abstract]   [Full Text] [Related]  

  • 15. Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds.
    Hirose M; Fukushima S; Hananouchi M; Shirai T; Ogiso T
    Gan; 1976 Apr; 67(2):175-89. PubMed ID: 964550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
    Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
    Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hirose M; Murasaki G; Imaida K; Fukushima S; Ito N
    Gan; 1980 Oct; 71(5):729-32. PubMed ID: 7227722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early surface changes of the urinary bladder epithelium of different animal species induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Shirai T; Murasaki G; Tatematsu M; Tsuda H; Fukushima S
    Gan; 1977 Apr; 68(2):203-12. PubMed ID: 892294
    [No Abstract]   [Full Text] [Related]  

  • 20. [A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine].
    Pliss GB; Vlasov NN; Iogannsen MG; Frolov AG
    Vopr Onkol; 1998; 44(4):432-5. PubMed ID: 9807207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.